HemaCare Co. (OTCMKTS:HEMA – Get Free Report) shares shot up 0.6% during mid-day trading on Tuesday . The company traded as high as $25.31 and last traded at $25.31. 5,400 shares were traded during trading, a decline of 86% from the average session volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Stock Up 0.6 %
The stock has a 50 day moving average of $25.31 and a 200 day moving average of $25.31.
HemaCare Company Profile
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Recommended Stories
- Five stocks we like better than HemaCare
- Top Stocks Investing in 5G Technology
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is the Euro STOXX 50 Index?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Dividend Capture Strategy: What You Need to Know
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.